Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Comirnaty
Biotech
Booster data close off opportunity for Valneva COVID-19 vaccine
Valneva’s trial found the vaccine elicited “only a marginally increased neutralizing antibody response” when used to boost Pfizer's Comirnaty.
Nick Paul Taylor
Jan 3, 2023 8:55am
FDA advisers recommend future boosters use omicron variant
Jun 28, 2022 8:15pm
Bavarian Nordic sets up COVID booster for Comirnaty battle
Jun 16, 2022 11:27am
Shionogi's COVID jab matches Pfizer's Comirnaty in booster trial
Mar 4, 2022 8:55am
Pfizer, BioNTech launch trial for omicron-busting vaccine
Jan 25, 2022 10:11am
Pfizer development head MacKenzie to retire in early 2022
Oct 6, 2021 3:10pm
